{"database":"EGA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"dataset_type":["Complete Genomics;COMPLETE_GENOMICS"],"full_dataset_link":["https://ega-archive.org/datasets/EGAD00001003120"],"sample_count":["6"],"description":["EGA dataset EGAD00001003120"],"repository":["EGA"],"title":["Whole-genome sequencing (WGS) to characterise five metastatic tumours from a BRAF mutant melanoma patient who presented intrinsic resistance."],"description_synonyms":["WGS, B-RAF1, Genomics, malignant, Comparative, neoplasia, Neoplasms, NS7, BRAF1, neoplastic disease, Malignant Melanomas, Functional Genomics, Tumor, Malignant, Client, tumours, NEOPL, melanoma (disease), Melanomas, neoplastic growth, Structural, Melanoma, melanoma, Malignant Melanoma, Functional, AA120551, B-raf, neoplasm, RAFB1, resistance., cell process disease, tumor disease, Comparative Genomics, neoplasm (disease), Naevocarcinoma, AA387315, C87398, tumour, patient, disease of cellular proliferation, 9930012E13Rik, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS), metastatic, C230098H17, Braf-2, Patient, Braf2, Clients, Structural Genomics, malignant melanoma, D6Ertd631e, tumor, other neoplasm, NEOPLASMS BENIGN, Neoplastic Growth, Neoplasia, AA473386, Intrinsic, Tumors"],"name_synonyms":["Vasp, VASP, Data Set., DmelCG15112, ENHANCER OF ATNSI ACTIVITY, MENA, NDPP1, l(2)02029, Enb, enb, ENA, Ena, CG15112, ENA/VASP"],"additional_accession":[]},"is_claimable":false,"name":"ena-DATASET-PICR-22-12-2016-18:41:50:772-383 - samples","description":"We used WGS (Complete Genomics) to characterise five metastatic tumours from a BRAF mutant melanoma patient who presented intrinsic resistance.","dates":{"updated":"2017-07-26 15:39:29"},"accession":"EGAD00001003120","cross_references":{"TAXONOMY":["9606"],"EGA":["EGAC00001000095","EGAS00001000580"]}}